financial overview for fiscal year ended march 31, … › english › ir › overview › pdf ›...

44
1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi President & Chief Operating Officer Kobayashi Pharmaceutical Co., Ltd. May 1, 2014

Upload: others

Post on 03-Jul-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

1/44

Financial Overview for Fiscal Year Ended March 31, 2014

Akihiro KobayashiPresident & Chief Operating OfficerKobayashi Pharmaceutical Co., Ltd.

May 1, 2014

Page 2: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

2/44Today’s Topics

1. Consolidated Results for Fiscal Year Ended March 31, 2014

2. Forecasts for Fiscal Year Ending March 31, 2015

3. Priority Issues for Further Growth

4. Returns to Shareholders

Page 3: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

3/44

1. Consolidated Results for Fiscal Year Ended March 31, 2014

Page 4: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

4/44Highlights of Consolidated Financial Results

FY ended March 2013

FY ended March 2014

Increase(Decrease)

Amount Margin Amount Margin Amount Percentage

SalesMillion yen

121,532%

Million yen

127,293% Million yen

5,761%

4.7

Gross profit 69,799 57.4 73,099 57.4 3,299 4.7

Operating income 16,903 13.9 18,122 14.2 1,218 7.2

Ordinary income 18,677 15.4 18,769 14.7 91 0.5

Net income 12,176 10.0 12,307 9.7 130 1.1

EPS (yen) 297.37 - 300.55 - 3.18 1.1

Dividends (yen) 82 - 86 - 4 4.9

Sales : Sales of deodorizing air fresheners, body warmers and Netsusama Sheets sold overseas grew steadily.

Ordinary income: Ordinary income grew slightly due to a fall in equity in earnings of affiliates (Medicon, Inc.) and foreign exchange losses.

Net income : Net income increased for the 16th consecutive fiscal year, reaching the highest-ever level.

Page 5: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

181169

14.213.9

0

50

100

150

200

250

FY endedMarch 2010

FY endedMarch 2011

FY endedMarch 2012

FY endedMarch 2013

FY endedMarch 2014

10

11

12

13

14

15Operating incomeOperating margin

5/44Changes in Consolidated ResultsSales Operating income

(100 million yen) (100 million yen) (%)

1,2151,272

0

500

1,000

1,500

FY endedMarch2010

FY endedMarch2011

FY endedMarch2012

FY endedMarch2013

FY endedMarch2014

4.7% Up 7.2% Up

Page 6: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

6/44Increase (Decrease) in Operating Income(100 million yen)

181219

144169 4

30.4 4 5

12

0

50

100

150

200

250

Impa

ct o

f the

wea

ker y

en

(ove

rsea

s sub

sidiar

ies)

Factor for decreaseFactor for increase

GP SGA expenses

Oper

atin

g in

com

e for

FY

ende

d Ma

rch

2013

Incr

ease

in o

pera

ting

inco

me

along

with

sales

incr

ease

Cost

redu

ctio

n

Rise

in ra

w m

ater

ial p

rices

Loss

on

disp

osal

of

inve

ntor

y

Sales

pro

mot

ion

& ad

verti

sing

expe

nses

R&D

expe

nses

Com

mun

icatio

n ex

pens

es

Dist

ribut

ion

expe

nses

Othe

r

Oper

atin

g in

com

e for

FY

ende

d Ma

rch

2014

Page 7: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

7/44Net Income Increased for the 16th Consecutive Fiscal Year, Reaching the Highest-Ever Level

(100 million yen)

123

0

50

100

150

FY endedMarch 1998

FY endedMarch 2014

Reaching the highest-ever level

Page 8: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

8/44

Consumer Products Business (Sales at stores in Japan and Kiribai Chemical)

Page 9: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

9/44Changes in Sales and Operating Income(Sales at Stores in Japan and Kiribai Chemical)

1,011986

0

400

800

1,200

FY endedMarch 2010

FY endedMarch 2011

FY endedMarch 2012

FY endedMarch 2013

FY endedMarch 2014

Sales Operating income(100 million yen) (100 million yen) (%)

2.6% Up177174

17.517.7

0

50

100

150

200

250

300

FY endedMarch 2010

FY endedMarch 2011

FY endedMarch 2012

FY endedMarch 2013

FY endedMarch 2014

0

5

10

15

20

25Operating incomeOperating margin

1.5% Up

Page 10: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

10/44Sales by Product Category(Sales at Stores in Japan and Kiribai Chemical)

Year-on-Year Main factors

Total 103.7%Pharmaceutical

products 98.3% Sales of a remedy for obesity were sluggish due to the shrinking of the market.

Oral hygiene products 104.5% Sales of interdental cleaning tools and Shouyou

increased solidly.

Food products 106.9% Sales of nutritional supplements were strong.

Sanitary products 105.8% Sales of Keshimin and new skincare products grew steadily.

Deodorizing air fresheners 106.0% Sales of Bluelet, Kuruma no Shoshugen Clip, and

Shoshugen Kaoru Sticks were robust.

Household sundries 102.9% Sales of Kantan Senjomaru were strong.

Kiribai Chemical 93.4% Sales of body warmers were sluggish due to the warmer weather.

Sales

at S

tore

s in

Japa

nSales of deodorizing air fresheners grew steadily. Sales at stores in Japan stood at 103.7% of the previous year.

Sales of deodorizing air fresheners grew steadily. Sales at stores in Japan stood at 103.7% of the previous year. (Note) 102.6%

including KiribaiChemical

Page 11: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

11/44Oral Hygiene Product Feature (Sales were at 104.5% of the previous year.)

Shouyou brand

Chinese herbal

medicineToothbrush

New release

Tomarina brand

Cool type

New release

New release

Increased the frequency of TV advertising for interdental cleaning tools

◆ Shouyou, Tomarina, and interdental cleaning tools

In response to a rise in oral care awareness, we expanded our product lineups and increased our frequency of TV advertising, boosting sales of oral hygiene products.

In response to a rise in oral care awareness, we expanded our product lineups and increased our frequency of TV advertising, boosting sales of oral hygiene products.

Page 12: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

13/44Deodorizing Air Freshener Feature (Sales were at 106.0% of the previous year.)

Increasing demand for refills of Shoshugen Kaoru Sticks due to the spread of interior fragrance products and the acceleration of deodorizing air fresheners for cars led to sales expansion.

Increasing demand for refills of Shoshugen Kaoru Sticks due to the spread of interior fragrance products and the acceleration of deodorizing air fresheners for cars led to sales expansion.

◆ Shoshugen Kaoru Sticks and Kuruma no Shoshugen Clips

Kuruma noShoshugen ClipShoshugen Kaoru Stick in collaboration with Hibiya Kadan

Page 13: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

14/44

7.9 7.5

0

5

10

15

20

FY endedMarch 2006

FY endedMarch 2007

FY endedMarch 2008

FY endedMarch 2009

FY endedMarch 2010

FY endedMarch 2011

FY endedMarch 2012

FY endedMarch 2013

FY endedMarch 2014

New Product Contribution Rate (Excluding Mail-Order Business)

(%)

● In FY ended March 2014, we launched 39 new products (27 products in Spring and 12 products in Fall).

Examples of new products launched in FY ended March 2014

Page 14: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

15/44Promoting Reduction of Return Rate/Loss on Disposal

2127

2.7

2.9

0

10

20

30

40

50

FY endedMarch 2008

FY endedMarch 2009

FY endedMarch 2010

FY endedMarch 2011

FY endedMarch 2012

FY endedMarch 2013

FY endedMarch 2014

0

1

2

3

4

5

Loss on disposal Return rate

(%)(100 million yen)

● We were able to appropriately manage the shipment of seasonal products, in particular summer products.

Page 15: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

16/44

Consumer Products Business (International Division)

Page 16: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

17/44

(100 million yen) (100 million yen)

● Sales of Netsusama Sheets (for children and babies) grew steadily in China and Southeast Asia.

● Sales of body warmers were strong in the United States.

125

95

0

50

100

150

FY endedMarch 2010

FY endedMarch 2011

FY endedMarch 2012

FY endedMarch 2013

FY endedMarch 2014

2.2

-0.4

-6

-4

-2

0

2

4

6

FY endedMarch 2010

FY endedMarch 2011

FY endedMarch 2012

FY endedMarch 2013

FY endedMarch 2014

Sales Operating income/loss(after goodwill amortization)

32.6% Up

Changes in Sales and Operating Income(International Division)

Page 17: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

18/44

Mail Order Business

Page 18: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

19/44Changes in Business Results of Mail Order Business

(100 million yen) (100 million yen)

● Sales of the Hifmid series and Yasai to Kouso (Vegetables and Enzymes) increased solidly.

107101

0

40

80

120

FY endedMarch 2010

FY endedMarch 2011

FY endedMarch 2012

FY endedMarch 2013

FY endedMarch 2014

3.6

1.6

-6

-4

-2

0

2

4

6

FY endedMarch 2010

FY endedMarch 2011

FY endedMarch 2012

FY endedMarch 2013

FY endedMarch 2014

Sales Operating income/loss

125 % Up

5.6% Up

Page 19: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

20/44

2. Forecasts for Fiscal Year Ending March 2015

Page 20: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

21/44Highlights of Consolidated Financial Results Forecasts

Sales: We aim to increase sales by focusing on new product development, the Skincare business and the International business.Operating income: We plan to actively spend money for the advertisement and sales promotion of new skincare products.Net income: We aim to increase net income for the 17th consecutive fiscal year, achieving the highest-ever net income.

FY ended March 2014

FY ending March 2015

Increase(Decrease)

Amount Margin Amount Margin Amount Percentage

SalesMillion yen

127,293% Million yen

132,000%

Million yen

4,706%

3.7

Gross profit 73,099 57.4 77,000 58.3 3,900 5.3

Operating income 18,122 14.2 18,400 13.9 277 1.5

Ordinary income 18,769 14.7 19,000 14.4 230 1.2

Net income 12,307 9.7 12,500 9.5 192 1.6

EPS (yen) 300.55 - 305.27 - 4.72 1.6

Dividends (yen) 86 - 86 - 0 0.0

Page 21: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

22/44

3. Priority Issues for Further Growth

Page 22: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

23/44Two Priority Issues

Enhancing our efforts to create new markets by developing new products and cultivating them to gain a foothold in the marketplace

Actively investing in prioritized businesses

We will focus our efforts on two priority issues, with the aim of growing our business further.

We will focus our efforts on two priority issues, with the aim of growing our business further.

1

2

Page 23: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

24/44Two Priority Issues

Actively investing in prioritized businesses

1

2

Enhancing our efforts to create new markets by developing new products and cultivating them to gain a foothold in the marketplace

Page 24: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

25/44

7.97.5

0

5

10

15

20

FY endedMarch 2006

FY endedMarch 2007

FY endedMarch 2008

FY endedMarch 2009

FY endedMarch 2010

FY endedMarch 2011

FY endedMarch 2012

FY endedMarch 2013

FY endedMarch 2014

Management Indicators

(%)

Kobayashi Pharmaceutical’s growth model is the creation of a new market by developing new products.We set a new product contribution rate of greater than 10% in the initial year as one of our management indicators.

Kobayashi Pharmaceutical’s growth model is the creation of a new market by developing new products.We set a new product contribution rate of greater than 10% in the initial year as one of our management indicators.

◆ New Product Contribution Rate (excluding Mail-Order Business)

Examples of new products launched in FY ended March 2014

Page 25: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

26/44

(i) Develop products with new valuesIdentify latent needs that go unnoticed even by our customers and

transform them into actual products to satisfy such needs.

With the following 3 viewpoints of customers in mind, we will focus on developing new products that customers really want to purchaseor that customers really use.

With the following 3 viewpoints of customers in mind, we will focus on developing new products that customers really want to purchaseor that customers really use.

◆ Strengthen product development capabilities

Enhancing Our Efforts to Create New Markets: Development

(ii) Develop products with features customers find attractive Gather and analyze data and information on customers' repeat

purchase intentions to develop products with features (includingquality) that entice customers to purchase again.

(iii) Develop products with consistency in mindGive sufficient considerations to naming, packaging, advertising, and

sales promotion goods, to give customers a consistent concept of the product.

Page 26: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

27/44

August 2013 September October November December January

2014 February March April

Topic

Closed campaign(Placing postcards)

◎ ◎

Featured items ◎ ○

Magazines ◎◎ ◎ ◎ ◎ ○ ◎◎

Explanation on the product

Special story about the

developmentNotification of

campaignProgress

at the midpoint

TVCF ◎ ○ ◎ ◎

Introduction

Dogs HAPPY Campaign

Release of fragrance-free

productsRelease

Soliciting applications by postcard

ワンダフル

キャンペーン

事務局行

住所氏名年齢電話

応募券3口

Third stageSecond stage

Prepared a six-month cultivation planLink advertisements to in-store sales campaigns to boost sales

Prepared a six-month cultivation planLink advertisements to in-store sales campaigns to boost sales

Enhancing Our Efforts to Create New Markets: Cultivation◆ Example of cultivation: Shoshugen Inu no Kimochi

(launched in August 2013)

Cont

inui

ng cu

ltiva

tion

At st

ores

Adve

rtise

men

t

Page 27: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

28/44Enhancing Our Efforts to Create New Markets: Cultivation

Total shipments from August 2013 to

March 2014

Progress rate of sales compared to the sales target in the first year

340 million yen 42.3%

<Our shipments in value>

Although the progress rate has been slow so far, we feel the product has been steadily establishing a foothold in the marketplace because we were able to boost sales at the stores according to our plan. We will try to cultivate it further.

Although the progress rate has been slow so far, we feel the product has been steadily establishing a foothold in the marketplace because we were able to boost sales at the stores according to our plan. We will try to cultivate it further.

<Change in actual sales at stores>

0

10,000

20,000

30,000

40,000

50,000

8月 9月 10月 11月 12月 1月 2月 3月

* Sales target in the first year: 800 million yen

◆ Example of cultivation: Shoshugen Inu no Kimochi(launched in August 2013)

(1,000 yen)

August 2013 September October November December January

2014 February March

(Source: Kobayashi Pharmaceutical)

Page 28: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

29/44

We aim to have two to four new products gain a foothold in the market every year through cultivation.We will nurture a product that creates a new market, staying in the market as a household name after 5 years or 10 years from the launch of it.

We aim to have two to four new products gain a foothold in the market every year through cultivation.We will nurture a product that creates a new market, staying in the market as a household name after 5 years or 10 years from the launch of it.

◆ Efforts to raise the percentage of new products that gain a foothold in the market through cultivation

Select a product with

growth potential as a

product to cultivate.

A product that creates

a new market

Enhancing Our Efforts to Create New Markets: Cultivation

Select one product as a product to cultivate. Cultivation plan

Prioritized product

Cultivationplan

The whole company is involved in cultivation.

<Past>

<Future>

At the time of release 6 months to 1 year later

Prioritized product

Prioritized product

Cultivationplan

Cultivationplan

Page 29: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

30/44Two Priority Issues

Enhancing our efforts to create new markets by developing new products and cultivatingthem to gain a foothold in the marketplace

Actively investing in prioritized businesses

1

2

Page 30: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

31/44

Actively invest in three businesses that will support future growth. Actively invest in three businesses that will support future growth.

Prioritized Business

Skincare Business

国際事業

Mail Order Business

Prio

ritize

d Bu

sines

s

InternationalBusiness

Page 31: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

32/44

Last year, we acquired two companies to expand the skincare business. Sales of the skincare business segment grew to 4,900 million yen in FY ended March 2014.

Last year, we acquired two companies to expand the skincare business. Sales of the skincare business segment grew to 4,900 million yen in FY ended March 2014.

September 2013Juju Cosmetics

Kobayashi Pharmaceutical

March 2013Rokuyo Pharmaceutical

Skincare Business◆ Expanding business through M&A

Page 32: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

33/44

Rough skin and pimples Moisturizing Aging

We have a wide selection of brands covering the main categories. We aim to create a new market in the skincare category by strengthening each brand and developing new products.

We have a wide selection of brands covering the main categories. We aim to create a new market in the skincare category by strengthening each brand and developing new products.

Blotches

Skincare Business◆ Product lineup by category

[New] Combination skin

EAUDE MUGE AQUA MOIST Keshimin BalancinaMadame Juju

Page 33: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

34/44Skincare Business

In April 2014, we established the Skincare Division and the Beauty Care Sales Division.We consolidated the Kobayashi Pharmaceutical Group's skincare technology and sales resources.

In April 2014, we established the Skincare Division and the Beauty Care Sales Division.We consolidated the Kobayashi Pharmaceutical Group's skincare technology and sales resources.

◆ Establishment of development and sales organizations

Kobayashi Pharmaceutical

Juju Cosmetics

RokuyoPharmaceutical

Skincare Division(Development and marketing)

<Past> <April 2014 ~>

Beauty Care Sales Division

Koba

yash

i Ph

arm

aceu

tical

Page 34: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

35/44Skincare Business

Kobayashi Pharmaceutical

Juju Cosmetics RokuyoPharmaceutical

Brand powerIngredient development technology

Marketing capacityCapacity to develop products in a short periodSales capacity

Brand powerCapability to offer proposals on stores

・Consumers information・Evaluating and analyzing technology・Quality standards (safety), etc.

Centralization

We have centralized the technology and assets that each company owns separately by consolidating organizations. We will strengthen development by horizontally spreading each company's strengths.

We have centralized the technology and assets that each company owns separately by consolidating organizations. We will strengthen development by horizontally spreading each company's strengths.

◆ Further business expansion

Page 35: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

36/44

We will aim to achieve sales of 10,000 million yen for FY ending March 2018, four years later, by upgrading the business foundation through the strengthening of product development and sales capabilities.

We will aim to achieve sales of 10,000 million yen for FY ending March 2018, four years later, by upgrading the business foundation through the strengthening of product development and sales capabilities.

Skincare Business◆ Business goal

100

49

2014.3期 2015.3期 2016.3期 2017.3期 2018.3期

New product

New product

(100 million yen)

FY ended March 2014

FY ending March 2015

FY ending March 2016

FY ending March 2017

FY ending March 2018

Page 36: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

37/44

China

United States

International Business◆ Business strategies

We will strengthen locally rooted marketing, mainly in 3 key regions: the United States, China, and Southeast Asia. We will continue to focus on the sales of body warmers, cooling gel sheets, and an external anti-inflammatory.

We will strengthen locally rooted marketing, mainly in 3 key regions: the United States, China, and Southeast Asia. We will continue to focus on the sales of body warmers, cooling gel sheets, and an external anti-inflammatory.

Southeast Asia

Page 37: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

38/44International Business

• We will enhance our efforts to display HeatMax's HOTHANDS in front of cashiers of mass retailers.

• We will try to increase the number of stores handling our body warmers by enhancing our sales efforts in alliance with Grabber, a sales company for body warmers, we acquired in 2012.

To promote daily use as a countermeasure against the cold, we will strengthen our efforts to display the products in front of cashiers.

To promote daily use as a countermeasure against the cold, we will strengthen our efforts to display the products in front of cashiers.

◆ United States: Body warmers

Page 38: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

39/44International Business

<Body warmers>•We will enhance our efforts to cultivate the market for our body warmers in inland areas by marketing our economically priced body warmer (priced at 2 yuan, normally 3.3 yuan), with the aim of increasing the number of stores handling our body warmers to 50,000. •We will try to raise product recognition by actively using in-store advertisements and sales promotion campaigns.

We will expand sales channels for economically priced body warmers in inland areas and enhance our efforts to market cooling gel sheets for babies.

We will expand sales channels for economically priced body warmers in inland areas and enhance our efforts to market cooling gel sheets for babies.

◆ China: Body warmers and cooling gel sheets

< Cooling gel sheets>•We will try to increase the number of stores handling our cooling gel sheets for babies, which are selling well, supported by the one-child policy.•We will continue running TV commercials focused on babies to make the use of our cooling gel sheet as a part of daily habits.<Production facility>•To cope with the expansion of demand for body warmers and cooling gel sheets, we plan to commence the operation of a new plant in Anhui Province this fall.

Page 39: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

< Cooling gel sheets>•We will try to increase the number of stores handling our cooling gel sheets for babies, which are selling well, as in China.•We will continue promoting our cooling gel sheets as a heat relief remedy in Hong Kong and Malaysia, where the market has been established.< External anti-inflammatory products>•We will strongly promote our product brands by unifying the packaging logos in Hong Kong, Malaysia, Singapore, etc., where we have had a track record for many years.•We will aim to launch sales of the products in other Southeast Asian countries at an early stage bypromptly obtaining Pharmaceutical Affairs regulatory approval in each country.

40/44International Business

We will strive to establish a foundation for creating a new market.We will strive to establish a foundation for creating a new market.

◆ Southeast Asia: Cooling gel sheets and external anti-inflammatory products

Page 40: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

40/44Mail Order Business

<Nutritional supplements>•We will strengthen our research in materials by placing Enzymesas the most focused area. We will plan to establish a study group in alliance with universities and enterprises.<Hifmid>•We will revamp the products after 10 years from the launch. We will plan to improve ingredientsand expand the product lineups.<Aloe>•We will promote our research on materials and strengthen the product lineups. We started marketing the Ikujyun Eki series in Fall 2013. <Campaign>•We will expand sales through the Mail Order Business 15th anniversary campaign.

We will upgrade research activities, our strength, to develop high-quality new products.

We will upgrade research activities, our strength, to develop high-quality new products.

◆ Business strategies

Page 41: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

41/44

4. Returns to Shareholders

Page 42: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

42/44Changes in Dividends and Payout Ratios

(%)(Yen)

● We increased dividends for the 15th consecutive fiscal year.

8682

28.627.6

0

20

40

60

80

100

'99/3 '14/30

10

20

30

40

配当金額 配当性向

FY ended March 1999

FY ended March 2014

Dividend amount

Dividend payout ratio

Page 43: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

43/44Returns to Shareholders

+

[Annual dividends]86 yen

[Acquisition of treasury stock]1,500 million yen (planned)

Returns to shareholders in FY ending March 2015

Page 44: Financial Overview for Fiscal Year Ended March 31, … › english › ir › overview › pdf › fye...1/44 Financial Overview for Fiscal Year Ended March 31, 2014 Akihiro Kobayashi

44/44